CN85107279A - 吡啶衍生物的制备方法及其组合物 - Google Patents

吡啶衍生物的制备方法及其组合物 Download PDF

Info

Publication number
CN85107279A
CN85107279A CN198585107279A CN85107279A CN85107279A CN 85107279 A CN85107279 A CN 85107279A CN 198585107279 A CN198585107279 A CN 198585107279A CN 85107279 A CN85107279 A CN 85107279A CN 85107279 A CN85107279 A CN 85107279A
Authority
CN
China
Prior art keywords
chemical formula
carbon atoms
group
formula
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198585107279A
Other languages
English (en)
Chinese (zh)
Inventor
埃利默·埃瑟
卡尔曼·哈森伊
哈纳尔卡·维卡·尼·比索
朱迪特·马塔茨
拉斯洛·斯波尔尼
埃斯特·少尔诺基
克萨巴·古西
弗朗克·特里施勒
比拉·赫格杜斯
马塔·卡波尔纳斯·尼·帕普
安娜·卡拉·尼·索霍尼亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Chemical Works of Gedeon Richter Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical Works of Gedeon Richter Ltd filed Critical Chemical Works of Gedeon Richter Ltd
Publication of CN85107279A publication Critical patent/CN85107279A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN198585107279A 1984-10-05 1985-09-30 吡啶衍生物的制备方法及其组合物 Pending CN85107279A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU843777A HU194830B (en) 1984-10-05 1984-10-05 Process for the production of derivatives of piridine
HU3777/84 1984-10-05

Publications (1)

Publication Number Publication Date
CN85107279A true CN85107279A (zh) 1986-09-17

Family

ID=10965443

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198585107279A Pending CN85107279A (zh) 1984-10-05 1985-09-30 吡啶衍生物的制备方法及其组合物

Country Status (22)

Country Link
US (1) US4624959A (enExample)
EP (1) EP0177054B1 (enExample)
JP (1) JPS6191173A (enExample)
KR (1) KR860003225A (enExample)
CN (1) CN85107279A (enExample)
AT (1) ATE40687T1 (enExample)
AU (1) AU580096B2 (enExample)
DD (1) DD238230A5 (enExample)
DE (1) DE3568164D1 (enExample)
DK (1) DK455185A (enExample)
ES (3) ES8705391A1 (enExample)
FI (1) FI853868A7 (enExample)
GR (1) GR852408B (enExample)
HU (1) HU194830B (enExample)
IL (1) IL76578A (enExample)
IN (1) IN162569B (enExample)
NO (1) NO853937L (enExample)
PH (1) PH21375A (enExample)
PL (1) PL147097B1 (enExample)
PT (1) PT81257B (enExample)
YU (1) YU158285A (enExample)
ZA (1) ZA857677B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59201461A (ja) * 1983-04-28 1984-11-15 Toshiba Corp 読み出し専用半導体記憶装置およびその製造方法
HU192875B (en) * 1984-10-05 1987-07-28 Richter Gedeon Vegyeszet Process for preparing 2-pyridinethiol derivatives
US5028716A (en) * 1989-01-30 1991-07-02 Taisho Pharmaceutical Co., Ltd. 3,5-diamino-1,2,4-triazole derivatives
CA2286862A1 (en) * 1997-04-11 1998-10-22 David Mendel Combinatorial libraries of peptidomimetic aminothioether acids
AR029289A1 (es) 2000-07-05 2003-06-18 Ishihara Sangyo Kaisha Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su proceso de produccion e intermediario para producirlo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT238200B (de) * 1962-03-27 1965-01-25 Degussa Verfahren zur Herstellung von neuen Pyridinderivaten
US4000285A (en) * 1975-04-03 1976-12-28 Smithkline Corporation 2,3-bis-(3-acyl-2-thioureido)-pyridines
US4260620A (en) * 1979-10-26 1981-04-07 Ciba-Geigy Corporation 2-Pyridinecarboxylic acids
JPS5798262A (en) * 1980-12-10 1982-06-18 Yoshitomi Pharmaceut Ind Ltd Pyridine derivative
US4563895A (en) * 1984-08-20 1986-01-14 Aluminum Company Of America Apparatus and method for ultrasonic detection of inclusions in molten metals

Also Published As

Publication number Publication date
IL76578A0 (en) 1986-02-28
DD238230A5 (de) 1986-08-13
AU4833085A (en) 1986-04-10
PH21375A (en) 1987-10-15
PT81257B (en) 1987-03-23
ZA857677B (en) 1986-06-25
FI853868L (fi) 1986-04-06
PL147097B1 (en) 1989-04-29
EP0177054B1 (de) 1989-02-08
IN162569B (enExample) 1988-06-11
JPS6191173A (ja) 1986-05-09
GR852408B (enExample) 1986-02-04
ES547603A0 (es) 1987-05-01
KR860003225A (ko) 1986-05-21
ES8706637A1 (es) 1987-07-01
DK455185D0 (da) 1985-10-04
HUT38908A (en) 1986-07-28
IL76578A (en) 1989-03-31
YU158285A (en) 1988-04-30
HU194830B (en) 1988-03-28
FI853868A0 (fi) 1985-10-04
EP0177054A1 (de) 1986-04-09
ATE40687T1 (de) 1989-02-15
DK455185A (da) 1986-04-06
FI853868A7 (fi) 1986-04-06
ES554311A0 (es) 1987-07-01
AU580096B2 (en) 1988-12-22
NO853937L (no) 1986-04-07
US4624959A (en) 1986-11-25
ES8706636A1 (es) 1987-07-01
PT81257A (en) 1985-11-01
ES8705391A1 (es) 1987-05-01
DE3568164D1 (en) 1989-03-16
ES554310A0 (es) 1987-07-01
PL255642A1 (en) 1987-10-05

Similar Documents

Publication Publication Date Title
CN1051074C (zh) 异噁唑－4－羧酰胺及羟基亚烷基氰基乙酰胺用于制备药物的用途
CN1045088C (zh) 用作pnp抑制剂的嘌呤和鸟嘌呤化合物
CN1036393C (zh) 7-(2-氨乙基)-苯并噻唑酮
CN1505628A (zh) 用于治疗由有害细胞因子活性引起的疾病的三唑化合物
CN87104970A (zh) 取代的氨基-5，6，7，8-四氢萘基氧代乙酸其制备方法及其作为药物的用途
CN1202168A (zh) 作为血清素拮抗剂的喹诺－2(1h)－酮衍生物
CN1094726A (zh) 噻唑烷二酮衍生物，它们的制备方法和用途
CN101048157A (zh) 代谢型谷氨酸受体的杂环二氢茚酮增强剂
CN1015054B (zh) N-吲哚基乙基-磺酰胺类的制备方法
CN1870999A (zh) 炔烃ⅰ
CN1030753A (zh) 制备新的取代n-(3-羟基-4-哌啶基)苯甲酰胺的方法
CN87107864A (zh) 咪唑啉酮化合物及其制备方法
CN88103784A (zh) 新的n-(4-哌啶基)双环缩合2-咪唑胺衍生物的制备方法
CN1033800A (zh) 茚满衍生物和其制备方法
CN1097006A (zh) O-芳基吗啡喃的醚类化合物
CN1305462A (zh) 具有止喘、抗变态反应、抗炎、免疫调节和神经保护作用的新的1,5和3－o－取代1h－吲唑类化合物,其制备方法以及作为药物的应用
CN1922179A (zh) 盐酸伐昔洛韦的结晶形式
CN1023219C (zh) 取代的咪唑衍生物的制备方法
CN1107843A (zh) 二氢化茚衍生物和其制法及合成该衍生物的中间体
CN1753886A (zh) 多元碱化合物的酸加成盐的制造方法
CN1023014C (zh) 麦角灵衍生物的制备方法
CN85107279A (zh) 吡啶衍生物的制备方法及其组合物
CN1402724A (zh) 作为抗糖尿病剂的新的噻唑烷二酮衍生物
CN1316994A (zh) 哌啶衍生物
CN85107284A (zh) 制备2-吡啶硫醇类衍生物和含有它们的药物配方的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication